Skip to main content
    S

    STAAR Surgical Company (STAA)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $21.50
    -0.51 (-2.32%)

    Market Cap: $1.10B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    90%(35/39)
    Avg Surprise
    +68.67%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.17
    Range$0.06 - $0.24
    7 analysts
    EPS Revisions
    3
    0
    7d
    3
    4
    30d
    EPS Estimate DriftChange to current
    90d ago$0.16+7.9%
    60d ago$0.170.0%
    30d ago$0.17+0.7%
    7d ago$0.17+0.7%
    Current$0.17
    Revenue Consensus
    $79M
    Range$73M - $85M
    10 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.36
    Range$-0.08 - $0.59
    7 analysts
    Revenue Consensus
    $86M
    Range$77M - $99M
    10 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.36---
    Sep 26EST
    		-$0.17---
    Jun 26
    Reported Aug 12
    		$0.18$0.05+260.00%Beat+238.5%
    Mar 26
    Reported May 13
    		$0.29$0.08+262.50%Beat+129.0%
    Dec 25
    Reported Mar 3
    		$0.01N/A-94.78%Miss+101.2%
    Sep 25
    Reported Nov 5
    		$0.30$0.05+500.00%Beat+50.0%
    Jun 25
    Reported Aug 6
    		$-0.13N/A+76.79%Beat-133.3%
    Mar 25
    Reported May 7
    		$-1.00$-0.60-66.67%Miss-1009.1%
    Dec 24
    Reported Feb 11
    		$-0.69$-0.03-2200.00%Miss-531.3%
    Sep 24
    Reported Oct 30
    		$0.20$0.18+11.11%Beat-33.3%
    Jun 24
    Reported Aug 7
    		$0.39$0.25+56.00%Beat-2.5%
    Mar 24
    Reported May 7
    		$0.11$0.06+83.33%Beat-38.9%
    Dec 23
    Reported Feb 26
    		$0.16$0.17-5.88%Miss+14.3%
    Sep 23
    Reported Nov 1
    		$0.30$0.18+66.67%Beat-18.9%
    Jun 23
    Reported Aug 2
    		$0.40$0.30+33.33%Beat-4.8%
    Mar 23
    Reported May 3
    		$0.18$0.09+100.00%Beat-37.9%
    Dec 22
    Reported Feb 21
    		$0.14$0.14+0.00%Beat-26.3%
    Sep 22
    Reported Nov 2
    		$0.37$0.21+76.19%Beat+76.2%
    Jun 22
    Reported Aug 10
    		$0.42$0.23+82.61%Beat+55.6%
    Mar 22
    Reported May 4
    		$0.29$0.15+93.33%Beat+45.0%
    Dec 21
    Reported Feb 23
    		$0.19$0.19+0.00%Beat+35.7%
    Sep 21
    Reported Nov 3
    		$0.21$0.17+23.53%Beat+40.0%
    Jun 21
    Reported Aug 4
    		$0.27$0.09+200.00%Beat+800.0%
    Mar 21
    Reported May 5
    		$0.20$0.03+566.67%Beat+400.0%
    Dec 20
    Reported Feb 24
    		$0.14$0.14+0.00%Beat+16.7%
    Sep 20
    Reported Nov 4
    		$0.15$0.09+66.67%Beat+25.0%
    Jun 20
    Reported Aug 5
    		$0.03$0.03+0.00%Beat-78.6%
    Mar 20
    Reported May 6
    		$0.04$0.03+33.33%Beat-55.6%
    Dec 19
    Reported Feb 26
    		$0.12$0.12+0.00%Beat+71.4%
    Sep 19
    Reported Oct 30
    		$0.12$0.08+50.00%Beat+71.4%
    Jun 19
    Reported Jul 31
    		$0.14$0.10+40.00%Beat+55.6%
    Mar 19
    Reported May 1
    		$0.09$0.05+80.00%Beat+125.0%
    Dec 18
    Reported Feb 21
    		$0.07$0.02+250.00%Beat+250.0%
    Sep 18
    Reported Oct 31
    		$0.07$-0.03+333.33%Beat+75.0%
    Jun 18
    Reported Aug 1
    		$0.09$0.01+800.00%Beat+1000.0%
    Mar 18
    Reported May 2
    		$0.04$-0.04+200.00%Beat+200.0%
    Dec 17
    Reported Feb 28
    		$0.02$-0.01+300.00%Beat+0.0%
    Sep 17
    Reported Nov 8
    		$0.04$0.02+100.00%Beat-
    Jun 17
    Reported Aug 2
    		$-0.01N/A+66.67%Beat-
    Mar 17
    Reported May 3
    		$-0.04$-0.06+33.33%Beat-
    Dec 16
    Reported Mar 2
    		$0.02$-0.02+200.00%Beat-

    Key Metrics

    Valuation
    P/E Ratio27.63EV/EBITDA39.48x
    Price/FCF-160.31xFCF Yield-0.62%
    Profitability
    Profit Margin1.13%Operating Margin10.90%
    ROE1.09%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio4.66xQuick Ratio4.03x
    Trading Statistics
    Beta1.18Avg Volume1.01M
    52-Week High$35.8752-Week Low$15.59

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$22.21
    SMA 20$21.51
    SMA 50$22.81
    SMA 200$23.59
    EMA 10$21.92
    EMA 20$21.99
    EMA 50$22.88
    EMA 200$23.90

    MACD

    Line: -0.21Signal: -0.32Hist: 0.11

    ADX

    ADX: 16.4+DI: 14.9-DI: 20.1

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down48.0
    PSAR$20.25

    Bollinger Bands

    Upper Band$23.60
    Lower Band$19.42
    %B Position1944%(Upper)
    Band Width0.50

    RSI (14-Day)

    Neutral
    44.8

    Momentum Oscillators

    Stoch %K68.3
    Stoch %D74.3
    Williams %R-37.5
    ROC (10d)-4.1%
    Momentum-0.93
    CCI (20d)6.2
    MFI (14d)53.3

    Volatility Measures

    ATR (14d)$0.97(4.5%)
    StdDev (20d)1.05
    Hist Vol52.6%(High)

    Volume Flow

    VWAP$21.63
    OBV52.6M
    AD Line20.2M
    CMF (20d)-0.062

    Volume Metrics

    Avg Vol (20d)1.0M
    Vol Ratio0.4x(Low)
    VWMA (20d)$21.31

    Pivot Points

    R3$23.11
    R2$22.60
    R1$22.31
    Pivot Point$21.80
    S1$21.51
    S2$21.00
    S3$20.71

    Advanced Oscillators

    TSI-5.85
    Ultimate Osc52.6
    KST-40.86

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$93.53M$93.52M$57.80M$94.73M$44.32M$42.59M$48.95M$88.59M$99.00M$77.36M$76.27M$80.31M
    Cost of Revenue$23.81M$24.66M$14.06M$16.86M$11.52M$14.58M$17.30M$20.10M$20.59M$16.32M$15.55M$16.67M
    Gross Profit$69.73M$68.86M$43.74M$77.88M$32.80M$28.00M$31.65M$68.49M$78.41M$61.03M$60.73M$63.64M
    Operating Expenses$59.63M$60.88M$66.58M$59.38M$62.76M$85.41M$59.56M$62.80M$66.51M$63.32M$50.32M$57.34M
    R&D$9.94M$9.93M$6.92M$9.21M$10.26M$11.34M$7.82M$12.25M$11.87M$13.38M$6.94M$11.47M
    SG&A$22.74M$17.02M$19.59M$20.76M$20.97M$24.46M$21.34M$21.68M$23.64M$23.23M$16.86M$19.27M
    Operating Income$10.10M$7.98M$-22,838,000$18.49M$-29,964,000$-57,401,000$-27,910,000$5.68M$11.90M$-2,281,000$10.40M$6.29M
    Interest Income$939,000$907,000$1.07M$790,000$1.37M$1.37M$1.55M$1.41M$1.42M$2.04M$1.70M$1.76M
    Interest Expense$0$0$0$0$0$0$2.42M$0$1.56M$0$0$0
    Income Before Tax$11.02M$8.22M$-20,652,000$18.79M$-25,915,000$-54,486,000$-30,334,000$13.16M$10.33M$-2,211,000$13.74M$6.75M
    Income Tax Expense$2.97M$3.01M$-2,343,000$9.91M$-9,103,000$-275,000$3.89M$3.18M$2.96M$1.13M$5.98M$1.93M
    Net Income$8.06M$5.21M$-18,309,000$8.88M$-16,812,000$-54,211,000$-34,228,000$9.98M$7.38M$-3,339,000$7.76M$4.82M
    EBITDA$13.42M$9.52M$-19,308,000$20.00M$-25,159,000$-53,462,000$-29,512,000$13.51M$10.43M$-3,011,000$13.25M$6.33M
    EBIT$10.09M$7.31M$-21,724,000$18.00M$-27,281,000$-55,852,000$-31,887,000$11.75M$8.91M$-4,248,000$12.04M$4.98M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about STAA

    Government Contracts

    Gov Obligations (TTM)
    $331300
    Gov Obligations / Revenue
    0.1%
    Obligations YoY
    N/A
    Active Awards
    3
    New Awards (TTM)
    0
    Avg Remaining Term
    11.9 mo

    Top agency: Department of Defense at 100.0% of trailing twelve month obligations across 1 agencies

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Stifel raises target for STAAR Surgical stock from USD 28 to USD 31

    Stifel has raised its price target for STAAR Surgical (STAA) stock from USD 28 to USD 31, citing stronger international sales momentum and potential recovery in China. This follows STAAR Surgical's strong second-quarter...

    ad-hoc-news.de•10/15/26•Bullish

    How Analyst Upgrade Will Impact STAAR Surgical Stock (STAA)

    STAAR Surgical has appointed a new VP of business development to boost its implantable lens portfolio amidst flat revenue and weaker returns. The company's investment narrative is now shaped by a new US$50 million share...

    Simply Wall Street•10/14/26•Neutral

    3 Reasons STAA is Risky and 1 Stock to Buy Instead

    This article identifies STAAR Surgical (STAA) as a risky investment due to flatlining revenue growth, limited distribution channels, and declining return on invested capital (ROIC). Despite a recent stock price drop...

    The Globe and Mail•10/12/26•Bearish

    STAAR Surgical (STAA) Stock Could Be Cheap As Shares Fell 82%

    STAAR Surgical's share price has dropped 81.6% over the last five years despite management highlighting new hires and product expansion...

    Simply Wall Street•10/12/26•Neutral

    STAAR Surgical Appoints Andrew Pilon, OD, as Vice President of Business Development

    STAAR Surgical Co. (NASDAQ: STAA) has appointed Andrew Pilon, OD, as its new vice president of business development. Dr. Pilon, who previously held a senior director role at Johnson & Johnson Vision...

    VisionMonday.com•10/12/26•Bullish

    STAA Valuation and Fair Value

    P/E
    27.6x
    Forward P/E
    62.5x
    EV/EBITDA
    39.5x
    P/FCF
    -160.3x
    PEG
    0.8x
    P/B
    3.0x
    See GNG's fair value

    STAA Profitability: Margins, ROIC and FCF

    Gross margin
    76.6%
    Operating margin
    10.9%
    Net margin
    1.1%
    ROE
    1.1%
    FCF margin
    -2.0%
    FCF yield
    -0.6%

    STAA Competitors

    CompanyTicker
    Amphastar PAMPH
    Teladoc IncTDOC
    Tandem Diabetes Care IncTNDM
    Procept Biorobotics CorpPRCT
    Omada Health, Inc. Common StockOMDA
    Replimune Group IncREPL
    Vor Biopharma IncVOR
    Immatics NVIMTX

    Sector: Healthcare

    STAA Analyst Ratings

    Consensus
    Hold
    Analysts
    12
    Strong Buy
    0
    Buy
    4
    Hold
    7
    Sell
    1
    Strong Sell
    0

    STAA Bull Case vs Bear Case

    Bull case

    • STAA grew quarterly revenue 111.0% year over year.

    STAA Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    -156.4%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.17
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    3 up, 4 down

    Frequently Asked Questions About STAA

    Does STAA pay dividends?

    STAAR Surgical Company (STAA) does not currently pay a regular dividend.

    What is STAA's P/E ratio?

    STAAR Surgical Company has a price-to-earnings (P/E) ratio of 27.63.

    What is STAA's market cap?

    STAAR Surgical Company (STAA) has a market capitalization of $1.10B with a current stock price of $21.50.

    Related stocks

    Sector: Healthcare

    All stocks starting with S

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In